Table 1 Patient characteristics and treatment effect of rivastigmine.
From: A pilot study of rivastigmine in the treatment of delirium after stroke: A safe alternative
Patient (gender) | Age (years) | IQCODE | Stroke localization | Stroke type | NIHSS | Highest daily dose (mg) | Effect | Delirium duration (days) |
|---|---|---|---|---|---|---|---|---|
1(F) | 69.2 | 53 | Right | PACI | 5 | 6 | Yes | 4 |
2(M) | 73.9 | 48 | Right | TACI | 15 | 9 | Yes | 6 |
3(M) | 85.0 | 70 | Right | POCI | 3 | 3 | Yes | 3 |
4(M) | 83.4 | 48 | Right | POCI | 6 | 9 | Yes | 11 |
5(M) | 80.7 | 48 | Right | PACI | 4 | 6 | Yes | 3 |
6(F) | 74.1 | 48 | Right | PACI | 3 | 3 | Yes | 2 |
7(M) | 53.4 | 48 | Left | PACI | 16 | 12 | Yes | 14 |
8(M) | 75.0 | 48 | Right | TACI | 11 | 12 | Yes | 17 |
9(M) | 82.5 | 48 | Right | POCI | 4 | 3 | Yes | 2 |
10(F) | 78.2 | 48 | Right | PACI | 2 | 9 | Yes | 11 |
11(M) | 85.5 | 58 | Right | LACI | 3 | 3 | Yes | 2 |
12(M) | 72.9 | 51 | Left | TACI | 20 | 6 | Yes | 5 |
13(F) | 72.8 | 78 | Left | ICH | 9 | 9 | No | 14 |
14(M) | 86.5 | 48 | Left | LACI | 7 | 9 | Yes | 8 |
15(F) | 79.3 | 48 | Left | PACI | 9 | 6 | Yes | 4 |
16(M) | 76.6 | 48 | Left | ICH | 15 | 6 | Yes | 8 |
17(F) | 79.4 | 48 | Left | ICH | 9 | 9 | Yes | 7 |